Clear market notes built around the JSE, the rand, and what matters locally.

2026-10-12 11:35 • The Motley Fool Positive Axe Cap view: Selective

Popular S&P 500 and Nasdaq-100 index funds hold nearly identical tech-heavy portfolios, creating significant overlap for investors seeking diversification. The article examines how major ETFs like VOO and QQQM concentrate heavily in the same mega-cap tech stocks (Nvidia, Apple, Microsoft, Alphabet, Amazon), and suggests dividend-focused ETFs like SCHD and DGRO as alternatives for those concerned about tech concentration and potential AI bubble risks.

Axe note: Holding both S&P 500 and Nasdaq-100 ETFs means heavy exposure to the same handful of tech giants, risking a tech bubble fallout.

2026-10-12 11:22 • The Motley Fool Positive Axe Cap view: Selective

Oppenheimer analyst Jay Olson raised his price target on Viking Therapeutics to $120 from $100, implying a potential quadrupling from the current $28.50 price. The bullish call is based on positive maintenance trial data for VK2735, a GLP-1 and GIP agonist drug, which increased the probability of success from 80% to 90%. Wall Street consensus projects VK2735 could generate $1.5 billion in 2030 sales rising to $6.5 billion by 2035, potentially capturing market share from Eli Lilly's tirzepatide, which is expected to reach $80 billion in total sales by 2030.

Axe note: Oppenheimer’s bullish call on Viking Therapeutics hinges on promising drug trial data but offers little for local investors beyond rand sensitivity.

2026-10-12 11:07 • The Motley Fool Neutral Axe Cap view: Neutral

Micron Technology has experienced explosive growth driven by AI infrastructure demand, with revenue up 379% and net income up 816% in fiscal Q4. However, the article warns that the memory industry's historical boom-bust cycles, combined with massive planned production capacity increases and Chinese competition, suggest the current AI boom may not sustain. The stock's low 7x forward earnings valuation reflects Wall Street's skepticism about long-term growth prospects.

Axe note: Micron's stellar recent gains on AI demand come with significant risks tied to industry cycles and rising global capacity.